MyFinsight
Home
Blog
About
Contact
Download
Download image
In-process research and
development, net of...
$92,226,562
Goodwill
$9,346,796
Deposits
$38,062
Inventory
$22,639,342
Cash and cash
equivalents
$7,721,393
Accounts receivable, net
of allowances
$4,049,111
Prepaid expenses
$3,535,287
Total other assets
$101,611,420
Total current assets
$37,945,133
Operating lease
right-of-use asset, net
$835,177
Total assets
$140,391,730
Total liabilities and
equity
$140,391,730
Total equity
$93,467,970
Total liabilities
$46,923,760
Total citius
pharmaceuticals, inc....
$79,958,162
Non-controlling interest
$13,509,808
Total current
liabilities
$38,207,120
Deferred tax liability
$8,035,000
Operating lease liability
noncurrent
$681,640
Accumulated deficit
-$247,024,914
Additional paid-in capital
$326,960,700
License payable
$18,250,000
Accounts payable
$11,021,412
Accrued expenses
$4,693,307
Accrued compensation
$3,094,395
Note payable
$1,000,000
Operating lease liability
$148,006
Common stock - 0.001 par
value 250,000,000...
$22,376
Back
Back
Balance Sheet
source: myfinsight.com
Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. (CTXR)